BioShai

Blood Test for Early Detection of Parkinsons Disease

Health Tech & Life Sciences
Non Active, Oct 2022 ceased to operate
Mature Yokne'am Illit Founded 2014
Website ↗
Total raised
Last: Undisclosed 2014-01
Stage
Mature
Founded
2014
Headcount
6
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences

About

BioShai is developing PDx, a simple blood test for the early diagnosis of Parkinsons disease. PDx is based on the measurement of the level of expression of a set of genes. The test can be combined with other clinical data to provide a more complete diagnosis and help physicians decide on the best course of treatment. BioShai is a portfolio company of Youdim Pharmaceuticals incubator.

Funding history · 1 round · — total

2014-01
Undisclosed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratories
Business model
B2B

Highlights

1 Patents

Tags

medical-technologieshospitalsdoctorsgenomicsclinicsearly-detectionhealthcare-providersblood-testbiotechnologydiagnosticsparkinsonbiomarkerspharma-companiesacademia